Please login to the form below

Not currently logged in
Email:
Password:

patient safety

This page shows the latest patient safety news and features for those working in and with pharma, biotech and healthcare.

Time running out for ‘no-deal’ Brexit medicines laws

Time running out for ‘no-deal’ Brexit medicines laws

However the General Pharmaceutical Council (GPhC) has argued against the latter, claiming that it could put patient safety at risk as prescribers may no longer be qualified to do so in

Latest news

More from news
Approximately 71 fully matching, plus 217 partially matching documents found.

Latest Intelligence

  • AstraZeneca’s oncology renaissance AstraZeneca’s oncology renaissance

    So how did AstraZeneca achieve this turnaround? In 2010 Mene Pangalos introduced a ‘5R framework’ for R&D: right target, right patient, right tissue, right safety, right commercial potential.

  • In conversation with Pfizer’s Erik Nordkamp In conversation with Pfizer’s Erik Nordkamp

    Both in terms of productivity gains, healthcare outcomes, and patient and healthcare professional experience. ... This is an educational approach for junior doctors and is designed to increase patient safety and reduce human error by improving

  • Changes to look out for in Medical Devices Regulations Changes to look out for in Medical Devices Regulations

    at the time and damaged the confidence of patients, consumers and healthcare professionals in the safety of medical devices’. ... fear for patient safety.

  • Transparency and accountability: tackling opacity and blame head-on Transparency and accountability: tackling opacity and blame head-on

    First do no harm’ is a fundamental tenet of medicine that rightly enshrines patient safety. ... For example, many clinicians are now using tools like WhatsApp to more efficiently answer questions, collaborate with colleagues and improve patient care

  • Brexit Means Brexit Brexit Means Brexit

    As the ABPI says: “It is now critical that both sides prioritise patient safety in phase two of the negotiations.”. ... But it should also begin, privately at least, to stress the potential consumer impacts an alternative position might bring; the

More from intelligence
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics